Paul Goode
Insider Reports History
- Location
- St. Louis, MO
- Signature
- /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Paul Goode:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Glucotrack, Inc. | Chief Executive Officer, Director | Common Stock, par value $0.001 per share | 339 | $1,650 | $4.87 | 25 Mar 2025 | Direct |
| GlucoTrack, Inc. | Chief Executive Officer, Director | Stock option (right to buy) | 3,277 | 14 Jun 2024 | Direct | ||
| GlucoTrack, Inc. | Chief Executive Officer, Director | Warrants to Purchase Common Stock | 2,100 | 01 Jul 2024 | Direct | ||
| GlucoTrack, Inc. | Chief Executive Officer, Director | Series A Common Warrant | 796 | 14 Nov 2024 | Direct | ||
| GlucoTrack, Inc. | Chief Executive Officer, Director | Series B Common Warrant | 0 | 12 Mar 2025 | Direct | ||
| GlucoTrack, Inc. | Chief Executive Officer, Director | Convertible Promissory Note | $0 | 14 Nov 2024 | Direct |
Insider Reports Filed by Paul Goode
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GCTK | Glucotrack, Inc. | 25 Mar 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 07 Oct 2025, 19:26 |
| GCTK | GlucoTrack, Inc. | 01 Jul 2024 | 1 | $0 | 4 | Chief Executive Officer | 03 Jul 2024, 17:26 |
| GCTK | Glucotrack, Inc. | 14 Jun 2024 | 10 | +$10,004 | 4 | Chief Executive Officer, Director | 28 Mar 2025, 21:43 |
| GCTK | GlucoTrack, Inc. | 22 Apr 2024 | 0 | $0 | 3 | Chief Executive Officer | 24 Apr 2024, 21:00 |